DK0872246T3 - Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis - Google Patents

Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis

Info

Publication number
DK0872246T3
DK0872246T3 DK96939325T DK96939325T DK0872246T3 DK 0872246 T3 DK0872246 T3 DK 0872246T3 DK 96939325 T DK96939325 T DK 96939325T DK 96939325 T DK96939325 T DK 96939325T DK 0872246 T3 DK0872246 T3 DK 0872246T3
Authority
DK
Denmark
Prior art keywords
urolithiasis
removal
stones
medication
promote
Prior art date
Application number
DK96939325T
Other languages
English (en)
Inventor
Masuo Akahane
Yoshitaka Tomiyama
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Application granted granted Critical
Publication of DK0872246T3 publication Critical patent/DK0872246T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96939325T 1995-11-30 1996-11-29 Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis DK0872246T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34659995 1995-11-30
PCT/JP1996/003494 WO1997019700A1 (fr) 1995-11-30 1996-11-29 Nouveau medicament pour attenuer la douleur et favoriser l'elimination des calculs lies a l'urolithiase

Publications (1)

Publication Number Publication Date
DK0872246T3 true DK0872246T3 (da) 2003-06-10

Family

ID=18384525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96939325T DK0872246T3 (da) 1995-11-30 1996-11-29 Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis

Country Status (10)

Country Link
US (2) US6410560B1 (da)
EP (1) EP0872246B1 (da)
KR (1) KR19990071800A (da)
AT (1) ATE232740T1 (da)
AU (1) AU7639796A (da)
DE (1) DE69626312T2 (da)
DK (1) DK0872246T3 (da)
ES (1) ES2195021T3 (da)
PT (1) PT872246E (da)
WO (1) WO1997019700A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
WO2007061114A1 (ja) * 2005-11-28 2007-05-31 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療用医薬組成物
US10267796B2 (en) * 2010-10-25 2019-04-23 The Procter & Gamble Company Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25150A (en) * 1986-06-05 1991-03-13 Ciba Geigy Ag Novel pharmaceutical preparation for topical application

Also Published As

Publication number Publication date
ATE232740T1 (de) 2003-03-15
EP0872246A4 (en) 1999-03-24
WO1997019700A1 (fr) 1997-06-05
US6410560B1 (en) 2002-06-25
EP0872246A1 (en) 1998-10-21
ES2195021T3 (es) 2003-12-01
DE69626312D1 (de) 2003-03-27
AU7639796A (en) 1997-06-19
EP0872246B1 (en) 2003-02-19
US6376513B1 (en) 2002-04-23
DE69626312T2 (de) 2004-01-22
PT872246E (pt) 2003-07-31
KR19990071800A (ko) 1999-09-27

Similar Documents

Publication Publication Date Title
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
PT840601E (pt) Thip para o tratamento de desordens do sono
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
HUP0203198A2 (hu) Tramadolvegyület és görcsoldó hatóanyagot tartalmazó gyógyászati készítmény, eljárás az előállítására és alkalmazása
PT1333887E (pt) Metodo de tratamento de desordens musculares
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DK0835126T3 (da) Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser
DE69819110D1 (de) Ein Arzneimittel zur Behandlung von Fettleibigkeit und Verbesserung des lipidmetabolismus
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
DK0872246T3 (da) Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis
EP0744176A3 (en) Methods for inhibiting bone loss
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
IT1288399B1 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
MY136683A (en) Kappa opoid agonist for the treatment of irritable bladder
MA26648A1 (fr) Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation.
IT1278853B1 (it) Dispositivo distanziatore monouso per il trattamento delle artoprotesi dell'anca
CA2238621A1 (en) Novel drug for relieving pain and promoting the removal of calculi in urolithiasis
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
PL285854A1 (en) Therapeutical device, especially for treatment of sexual disorders in men